Drug Cos. Can't Nix Monitoring Class In Zantac MDL
By Mike Curley · October 7, 2021, 1:07 PM EDT
A Florida federal judge won't let drugmakers escape claims from a class alleging that their use of Zantac and its generics have given them an increased risk of cancer, saying the...
To view the full article, register now.